Targeting the Tumor Microenvironment
September 3, 2013
Boston, Nov 18-20
Rajendra Kumari, CSO & Founder, PRECOS Ltd will present on:
Humanising mouse models of cancer to expand drug development opportunities
- The potential role of paracrine signalling in targeting cancer development.
- Recapitulating PDX tumor models in 3D TGAs (Tumor Growth Assay) and animal models.
- The next generation of PDX and resistance models and their potential role to help screen for novel tumor microenvironment therapies.
Join us at the TME conference to hear more about our work.